Skip to main content
Veterinary Medicines

Laxatract 667 mg/ml oral solution

Authorised
  • Lactulose, liquid

Product identification

Medicine name:
Laxatract 667 mg/ml oral solution
Laxatract 667 mg/ml sirup pre psy a mačky
Active substance:
  • Lactulose, liquid
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Lactulose, liquid
    667.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Syrup
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA06AD11
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:
  • HDPE bottle closed with a (LDPE) syringe inlay and a (HDPE) cap. Cardboard box of 1 bottle of 50 ml with a 5ml oral syringe.
  • HDPE bottle closed with a (LDPE) syringe inlay and a (HDPE) cap. Cardboard box of 1 bottle of 125 ml with a 5ml oral syringe.
  • HDPE bottle closed with a (LDPE) syringe inlay and a cap (PP). Cardboard box of 1 bottle of 325 ml with a 10ml oral syringe.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Feramed B.V.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/061/DC/19-S
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0241/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 3/02/2022